fda glp-1 warning letters october 2025 March 31, 2025: Senator asks how will be accountable for unregulated active pharmaceutical ingredient (API) imports – Partnership for Safe Medicines Compounded" GLP-1 drugs | Health

Renal and urothelial cancer risks with SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes: a target trial emulation doi.org/10.1093/ndt/gf Renal and urothelial cancer risks with SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes: a target trial emulation doi.org/10.1093/ndt/gf

Abstract Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are increasingly being used to treat diabetes and obesity

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes

Common side effects include: Gastrointestinal Issues - This is the most common side effect, including constipation, cramps, diarrhea, nausea, vomiting, heartburn, and belching Fatigue Dizziness Allergic reactions, such as itching or rashes Injection site reactions (redness, swelling) Rare and more serious side effects can include: Pancreatitis Gallbladder issues Thyroid tumours Kidney problems Severe allergic reactions such as difficulty breathing and swelling of the face, lips, or throat Diabetic retinopathy Severe changes in mood or behaviour Please note that the more serious side effects are very rare

Vakalopoulos C

Sugar is famously empty calories, to use a phrase from nutrition